EHC/LinkedIn
Feb 15, 2026, 10:52
Awareness and Research on Factor V Deficiency Are Critical – EHC
European Haemophilia Consortium (EHC) shared a post on LinkedIn:
“Extremely Rare Bleeding Disorder of the Month: Factor V Deficiency
Nosebleeds that won’t stop. Bruises from nowhere.
Bleeding that just keeps going.
For people with this rare clotting disorder, these aren’t occasional issues—they’re part of life.
The condition can affect anyone at any age, but knowing the signs matters.
Right now, treatment options are limited, which is why awareness and research are so critical.
Want to learn more?
On the ERIN Focus Area page on our EHC Community website, you can find relevant webinars, podcasts, and publications.”
Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients